NCI vs LEVI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
NCI
LEVI
Investment Advisor Scores
LEVI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NCI | LEVI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 16.7785 | Tie |
| PEG Ratio | 1.13 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -50.8% | 4.3% | LEVI |
| Earnings Growth | 34.0% | -22.0% | NCI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 48.5/100 | 34.1/100 | NCI |
| Profit Margin | 0.2% | 8.8% | LEVI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | NCI |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NCI
MarkdownPrice below a falling SMA50 (slope -32.6%), weak momentum, RSI 16
LEVI
NeutralMixed signals - no dominant trend phase, RSI 63
Fundamentals Snapshot
| Metric | NCI | LEVI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 12.8 |
| Trailing P/E | 8.7 | 13.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.5% | 0.0% |
| Gross Margin | 0.4% | 0.6% |
| Operating Margin | 0.0% | 0.1% |
| EPS | 0.08 | 1.52 |
| Dividend Yield | — | 0.03% |